Lack of effects of acemetacin on signalling pathwaysfor leukocyte adherence may explain itsgastrointestinal safety
Ortiz Ramírez, Mario Isidoro
2008
Chávez-Piña AE, Vong L, McKnight W, Dicay M, Zanardo RC, Ortiz MI, Castañeda-Hernández G, Wallace JL. Lack of effects of acemetacin on signalling pathways for leukocyte adherence may explain its gastrointestinal safety. Br J Pharmacol. 2008;155(6):857-64. ISSN:1476-5381.
Abstract
Acemetacin is a non-steroidal anti-inflammatory drug which is rapidly bioconverted to indomethacin, but produces significantly less gastric damage than indomethacin. This study was performed to investigate several possible mechanisms that could account for the gastrointestinal tolerability of acemetacin.
Artículos relacionados
ACEMETACIN ANTINOCICEPTIVE MECHANISM IS NOT RELATED TO NO OR K+ CHANNEL PATHWAYS
Primary dysmenorrhea among Mexican university students: prevalence, impact and treatment
Antihyperalgesia Induced by Heliopsis longipes Extract
Effect of dietary selenium deficiency on the in vitro fertilizing ability of mice spermatozoa